ACTG A5324: Intensification of ART in People With HIV on Suppressive ART Does Not Improve Cognitive Impairment

Source: Conference Coverage of CROI 2022: Clinical Impact of New HIV Data*
Download Slideset
February 13-16, 2022; Virtual
Despite ART intensification in the treatment arms, performance on neuropsychologic testing improved similarly in all arms, including placebo, consistent with the practice effect.
Format: Microsoft PowerPoint (.ppt)
File Size: 462 KB
Released: February 17, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Cepheid
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings